vs
Ensysce Biosciences, Inc.（ENSC）与Token Cat Ltd（TC）财务数据对比。点击上方公司名可切换其他公司
Token Cat Ltd的季度营收约是Ensysce Biosciences, Inc.的1.5倍（$2.8M vs $1.9M），Token Cat Ltd净利率更高（-3.4% vs -147.0%，领先143.7%），Ensysce Biosciences, Inc.同比增速更快（44.4% vs -37.9%）
Ensysce Biosciences是一家临床阶段生物技术公司，专注于开发疼痛管理和肿瘤适应症领域的创新前药疗法，其专有平台可降低阿片类药物滥用风险并提升治疗有效性，面向全球医疗医药市场，重点解决未被满足的临床需求。
ENSC vs TC — 直观对比
营收规模更大
TC
是对方的1.5倍
$1.9M
营收增速更快
ENSC
高出82.3%
-37.9%
净利率更高
TC
高出143.7%
-147.0%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.9M | $2.8M |
| 净利润 | $-2.8M | $-93.0K |
| 毛利率 | — | 79.0% |
| 营业利润率 | -147.8% | -206.9% |
| 净利率 | -147.0% | -3.4% |
| 营收同比 | 44.4% | -37.9% |
| 净利润同比 | 22.3% | 98.3% |
| 每股收益（稀释后） | $-0.51 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENSCTC
| Q4 25 | $1.9M | — | ||
| Q3 25 | $493.1K | — | ||
| Q2 25 | $1.4M | $2.8M | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | — | $4.4M | ||
| Q4 23 | $515.0K | — |
净利润ENSCTC
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-3.7M | — | ||
| Q2 25 | $-1.7M | $-93.0K | ||
| Q1 25 | $-1.9M | — | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $661.8K | — | ||
| Q2 24 | — | $-5.6M | ||
| Q4 23 | $-3.5M | — |
毛利率ENSCTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 79.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 69.2% | ||
| Q4 23 | — | — |
营业利润率ENSCTC
| Q4 25 | -147.8% | — | ||
| Q3 25 | -758.7% | — | ||
| Q2 25 | -127.6% | -206.9% | ||
| Q1 25 | -149.1% | — | ||
| Q4 24 | -274.3% | — | ||
| Q3 24 | 18.9% | — | ||
| Q2 24 | — | -146.9% | ||
| Q4 23 | -612.7% | — |
净利率ENSCTC
| Q4 25 | -147.0% | — | ||
| Q3 25 | -756.3% | — | ||
| Q2 25 | -126.4% | -3.4% | ||
| Q1 25 | -147.4% | — | ||
| Q4 24 | -273.4% | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | -125.9% | ||
| Q4 23 | -680.4% | — |
每股收益（稀释后）ENSCTC
| Q4 25 | $-0.51 | — | ||
| Q3 25 | $-1.29 | — | ||
| Q2 25 | $-0.79 | — | ||
| Q1 25 | $-1.39 | — | ||
| Q4 24 | $-0.89 | — | ||
| Q3 24 | $1.00 | — | ||
| Q2 24 | — | — | ||
| Q4 23 | $-66.47 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $150.0K |
| 总债务越低越好 | — | $1.4M |
| 股东权益账面价值 | $3.2M | $4.6M |
| 总资产 | $7.5M | $28.4M |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资ENSCTC
| Q4 25 | $4.3M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $2.2M | $150.0K | ||
| Q1 25 | $3.1M | — | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $4.2M | — | ||
| Q2 24 | — | $689.0K | ||
| Q4 23 | $1.1M | — |
总债务ENSCTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $1.8M | ||
| Q4 23 | — | — |
股东权益ENSCTC
| Q4 25 | $3.2M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $3.4M | $4.6M | ||
| Q1 25 | $3.0M | — | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $6.9M | — | ||
| Q2 24 | — | $-787.0K | ||
| Q4 23 | $-322.9K | — |
总资产ENSCTC
| Q4 25 | $7.5M | — | ||
| Q3 25 | $3.2M | — | ||
| Q2 25 | $5.6M | $28.4M | ||
| Q1 25 | $4.6M | — | ||
| Q4 24 | $5.6M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | — | $12.5M | ||
| Q4 23 | $2.7M | — |
负债/权益比ENSCTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $-23.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ENSCTC
| Q4 25 | $-1.5M | — | ||
| Q3 25 | $-1.9M | — | ||
| Q2 25 | $-2.7M | $-23.7M | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-764.1K | — | ||
| Q3 24 | $-1.0M | — | ||
| Q2 24 | — | $-1.5M | ||
| Q4 23 | $-1.8M | — |
自由现金流ENSCTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-1.5M | ||
| Q4 23 | — | — |
自由现金流率ENSCTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -34.4% | ||
| Q4 23 | — | — |
资本支出强度ENSCTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.0% | ||
| Q4 23 | — | — |
现金转化率ENSCTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.54× | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
